Why did 4596.T stock spike pre-market today?

The pre-market spike was driven by heavy volume and market attention to Kubota’s clinical pipeline. The trade likely reflects speculative flows and anticipation of trial news or corporate updates rather than confirmed earnings beats.

What are the key support and resistance levels for 4596.T stock?

Immediate support sits at **JPY 59.00** (previous close). Short-term resistance is **JPY 93.00**, with a near-term target at **JPY 110.00** and a medium-term target near the year-high **JPY 144.00**.

How should investors weigh Meyka AI’s forecast for 4596.T stock?

Meyka AI's forecast shows monthly **JPY 44.36** and quarterly **JPY 46.73** versus current **JPY 90.00**. Use forecasts as one input among fundamentals, technicals, and clinical news. Forecasts are model-based and not investment advice.

What are the main risks for 4596.T stock investors?

Main risks include negative earnings, trial failure, regulatory delays, and sharp liquidity-driven swings. The company’s EPS is **-19.46**, which highlights profitability risk despite strong cash per share.

JP Stocks

27 Jan 2026: 4596.T up 52.54% pre-market, Kubota Pharmaceutical (JPX) high-volume mover

ByHuzaifa Zahoor January 26, 2026January 26, 2026

The 4596.T stock jumped 52.54% in pre-market trade on 27 Jan 2026 on very heavy volume. Price opened at JPY 75.00 and traded to a day high of JPY 93.00 before settling near JPY 90.00 in early trade. This move pushed volume to 25,925,500.00 shares, over four times the average daily flow. Traders are watching clinical catalysts and liquidity while the healthcare sector shows steady performance.